Balyasny Asset Management LLC Siga Technologies Inc Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.51 - $8.92 $70,779 - $139,990	15,694 Added 42.15%	52,929 $453,000
Q4 2023 Feb 14, 2024	BUY	$4.82 - $6.25 $179,472 - $232,718	37,235 New	37,235 $208,000
Q1 2023 May 15, 2023	SELL	$5.23 - $8.42 $69,030 - $111,135	-13,199 Reduced 41.83%	18,357 $105,000
Q4 2022 Feb 14, 2023	BUY	$7.29 - $10.14 $230,043 - $319,977	31,556 New	31,556 $232,000
Q2 2022 Aug 15, 2022	BUY	$6.5 - $13.68 $79,722 - $167,785	12,265 New	12,265 $142,000
Q3 2021 Nov 15, 2021	SELL	$5.71 - $7.39 $148,979 - $192,812	-26,091 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.1 - $7.58 $159,155 - $197,769	26,091 New	26,091 $164,000

185

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $432M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.